المؤلفون: A. Saraux, C Saillot, Aleth Perdriger, C. Lucas, E. Solau Gervais, E Ricard, Philippe Goupille, J.B. Cren, C Pereira Gillion, L. Joffres, M. Herbette, E. Bergeal, Béatrice Bouvard, Y. Maugars

المصدر: Abstracts Accepted for Publication.

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Retrospective cohort study, 02 engineering and technology, Neutropenia, 021001 nanoscience & nanotechnology, medicine.disease, 030226 pharmacology & pharmacy, Rheumatology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, chemistry, Internal medicine, Anesthesia, Rheumatoid arthritis, Cohort, Toxicity, medicine, 0210 nano-technology, Adverse effect, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::aabba2dab03960f9e6125c3e848216cf
https://doi.org/10.1136/annrheumdis-2017-eular.6008